Document:

<PAGE>

                                                                    EXHIBIT 10.8

                          EQUITY AND WARRANT AGREEMENT

         This EQUITY AND WARRANT AGREEMENT (this "Agreement"), dated as of July
31, 2002, is entered into among WellCare Holdings, LLC, a Delaware limited
liability company (the "Company"), and Kiran C. Patel, M.D., Pradip C. Patel and
Rupesh Shah, each a resident of the State of Florida (each a "Holder" and
collectively the "Holders").

                                    RECITALS

         A.       Reference is hereby made to the Amended and Restated Limited
Liability Company Agreement of the Company, dated as of the date hereof, as
amended from time to time (the "LLC Agreement").

         B.       Pursuant to that certain Contribution and Warrant Purchase
Agreement, dated as of the date hereof, between the Company and WellCare
Acquisition Company, a wholly-owned subsidiary of the Company ("Buyer"), as of
immediately prior to the effectiveness of this Agreement, Buyer has purchased
from the Company, and the Company has sold to Buyer, the Warrants (as herein
defined).

         C.       Pursuant to that certain Purchase Agreement, dated as of May
17, 2002 (the "Purchase Agreement"), by and among Well Care HMO, Inc.,
HealthEase of Florida, Inc., Comprehensive Health Management, Inc.,
Comprehensive Health Management of Florida, L.C. (collectively, the "Well Care
Group"). Buyer, the Holders and the other parties named therein, if any, each of
the Holders is hereby being transferred warrants to acquire Class B Common Units
(as such term is defined in the LLC Agreement) as partial consideration for the
sale of such Holder's shares of capital stock of and/or other equity securities
in the Well Care Group.

         D.       In consideration of such transfer of warrants, each Holder
agrees to abide by the obligations imposed under this Agreement.

         E.       The execution and delivery of this Agreement by each Holder is
a condition precedent to the obligation of the Company to consummate the
transactions contemplated by the Purchase Agreement.

         NOW, THEREFORE, in consideration of the covenants and promises set
forth herein, and for other good and valuable consideration (the receipt and
sufficiency of which are hereby acknowledged by the parties), intending to be
legally bound hereby, the parties agree as follows:

         1.       Defined Terms. Capitalized terms used and not otherwise
defined in this Agreement shall have the respective meanings ascribed thereto in
the Purchase Agreement.

         2.       Warrants; Warrant Units.

                  (a)      Grant of Warrants. The Company (on behalf of the
Buyer) hereby transfers to the Holders warrants (collectively, the "Warrants")
to purchase 6,861.111 Class B Common Units (the "Warrant Units") at an exercise
price of $1,000 per Class B Common Unit

<PAGE>

(the "Exercise Price"), which Warrants are allocated among the Holders as set
forth on Schedule A attached hereto. The Warrants will be exercisable at any
time during the period beginning on the date thirty (30) days after the date
hereof and ending on the date ten years after the date hereof (the "Exercise
Period").

                  (b)      Termination of the Warrants. Any and all Warrants
which have not been exercised as of immediately after the expiration of the
Exercise Period shall immediately terminate and be canceled and may not be
exercised thereafter under any circumstance.

                  (c)      Procedure for Exercise. At any time during the
Exercise Period, any Holder may exercise all (and not less than all) of the
Warrants owned by such Holder by delivering written notice of exercise to the
Company, together with payment in full of the aggregate Exercise Price of the
Warrant Units being purchased. Payment of such Exercise Price shall be made in
cash (by check, money order or wire transfer of immediately available funds) or
by executing and delivering to the Company a Non-Recourse Promissory Note with a
principal amount equal to such Exercise Price substantially in the form attached
hereto as Exhibit A. In addition, in connection with any exercise of any
Warrants, the applicable Holder will execute and deliver to the Company an
appropriate joinder to the LLC Agreement as required by the LLC Agreement.

                  (d)      Net Issue Exercise.

                           (i)      In lieu of exercising the Warrants on a cash
                                    basis pursuant to Section 2(c) hereof, any
                                    Holder may elect to exercise all (and not
                                    less than all) of the Warrants owned by such
                                    Holder during the Exercise Period on a
                                    net-issue basis by electing to receive the
                                    number of Warrant Units which are equal in
                                    value to the value of the Warrants owned by
                                    such Holder at the time of any such net-
                                    issue exercise, by delivering written notice
                                    of such net-issue exercise to the Company.

                           (ii)     In the event that any Holder shall elect to
                                    exercise the Warrants owned by such Holder
                                    on a net-issue basis pursuant to this
                                    Section 2(d) the Company shall issue to such
                                    Holder the number of Warrants Units
                                    determined in accordance with the following
                                    formula:

                                                X   =   Y(A-B)
                                                        ------
                                                           A

                                    X    =   the number of Warrant Units to be
                                             issued to such Holder in connection
                                             with such net-issue exercise.

                                       2
<PAGE>

                                    Y    =   the aggregate number of Warrant
                                             Units which would be issued if such
                                             Holder exercised such Warrants on a
                                             cash basis pursuant to Section 2(c)
                                             hereof.

                                    A    =   the Fair Market Value of a Warrant
                                             Unit.

                                    B    =   the Exercise Price in effect as of
                                             the date of such net- issue
                                             exercise (as adjusted pursuant to
                                             the terms hereof).

                  (e)      Fair Market Value. For purposes of Section 2(d)
hereof, the term "Fair Market Value" of any Warrant Unit, as of any given date
shall be the purchase price for such Warrant Unit which a willing buyer having
all relevant knowledge would pay a willing seller for such Warrant Unit in an
arm's-length transaction, as determined in good faith by the Company's board of
directors (the "Board") in accordance with valuation procedures which the Board
reasonably determines to be appropriate; provided, that (x) if such Fair Market
Value is being determined in connection with an Initial Public Offering (as such
term is defined in the LLC Agreement), then the offering price of such Initial
Public Offering will be used by the Board to determine such Fair Market Value
and (y) so long as such Warrant Unit is a Class B Common Unit, (i) the impact of
Section 10.2(b) of the LLC Agreement will be taken into account and (ii) except
as otherwise provided in clause (i) above, all Common Units (as such term is
defined in the LLC Agreement) shall be valued equally.

                  (f)      Record Ownership of Warrant Units. The Warrant Units
shall be deemed to have been issued, and the person in whose name any
certificate or instrument representing Warrant Units shall be issuable upon the
exercise of the Warrants (who shall be the person who owns the Warrants upon
their exercise) shall be deemed to have become the holder of record of (and
shall be treated for all purposes as the record holder of) the Warrant Units
represented thereby, immediately prior to the close of business on the date upon
which the Warrants are exercised in accordance with the terms hereof.

         3.       Restricted Units. For purposes of this Agreement, the term
"Restricted Units" means (i) all Class B Common Units or other equity securities
of the Company (or its successors) issued upon the proper exercise of any
Warrant and (ii) all equity securities issued with respect to the equity
securities referred to in clause (i) above by way of stock or unit dividend or
other distribution, or stock or unit split, or in connection with any
combination of shares or units, or in connection with any recapitalization,
merger, consolidation or other reorganization. The Restricted Units shall be
subject to the restrictions described in this Agreement.

         4.       Nontransferability. Neither any Warrants nor any Restricted
Units may be assigned, sold, transferred, exchanged, given, devised, pledged,
hypothecated or otherwise encumbered or disposed by any Holder, either
voluntarily or involuntarily by operation of law (including any transfer
pursuant to equitable distribution proceedings or pursuant to a divorce decree)
during the Restricted Period, except as otherwise specifically provided in this
Section 4. The provisions of this Section 4 shall not apply to the transfer or
re-transfer of any Warrants or Restricted Units by the Holder to or for the
benefit of (a) any spouse, parent, child, grandchild or lineal descendant
(including adopted children and step children) of the Holder (including

                                       3
<PAGE>

trustee(s) of a trust for the benefit of the Holder or any of the foregoing) and
(b) any legal representative, devisee or heir of the Holder upon his death;
provided, however, that in each such case all such transferees shall take such
Warrants and/or Restricted Units subject to all restrictions, terms, and
conditions of this Agreement and shall execute and deliver to the Secretary of
the Company a written agreement, in form and substance reasonably satisfactory
to the Company, to be bound by and comply with the provisions of this Agreement
prior to acquiring such Warrants and/or Restricted Units, and there shall be no
further transfer of such Warrants and/or Restricted Units except in accordance
with this Agreement.

         5.       Lapse of Restricted Period. The period during which the
Warrants and the Restricted Units are subject to the restrictions set forth in
Section 4 hereof (the "Restricted Period") shall commence on the date hereof and
shall lapse upon the closing of a public offering pursuant to a registration
statement filed with the Securities and Exchange Commission, and declared
effective under the Securities Act of 1933, as amended, covering the offer and
sale of common equity for the account of the Company (or any of its successors
or subsidiaries as described in Section 12.16 of the LLC Agreement).

         6.       Organic Change. Any recapitalization, reorganization,
reclassification, consolidation, merger, sale of all or substantially all of the
Company's assets or common equity securities or other transaction which is
effected in such a way that holders of Class B Common Units are entitled to
receive (either directly or upon subsequent liquidation) stock, securities or
assets with respect to or in exchange for Class B Common Units is referred to
herein as an "Organic Change." Except as otherwise provided herein, after the
consummation of any Organic Change, to the extent applicable each Warrant for
Warrant Units shall thereafter be exercisable for, rather than the applicable
Warrant Units immediately theretofore acquirable and receivable upon exercise of
such Warrant, such shares of stock, securities or assets (including cash) as may
be issued or payable with respect to or in exchange for the number and class of
Warrant Units immediately theretofore acquirable and receivable upon exercise of
such Warrant had such Organic Change not taken place. The Company shall provide
each holder of any Warrant with written notice within five (5) days after the
occurrence of any Organic Change, which notice shall describe in reasonable
detail, such Organic Change and the effect of such Organic Change on the
Warrants.

         7.       Adjustment for Change in Class B Common Units. In the event of
a recapitalization, reorganization or unit split, combination of units,
consolidation or merger which affects the number of outstanding Class B Common
Units, the Company shall, in order to prevent the dilution or enlargement of
rights under any Warrant, make appropriate changes in the number and type of
securities or other consideration covered by any unexercised Warrant which has
not expired and its Exercise Price as the Company determines, in good faith, to
be appropriate and equitable and shall promptly give notice, in reasonable
detail, of such changes to each holder of Warrants.

         8.       Rights as a Member. Except for the restrictions set forth
herein, upon the issuance of Class B Common Units to a Holder upon the exercise
of any Warrants, such Holder shall have all the rights and duties of a Member
(as such term is defined in the LLC Agreement) with respect to the Class B
Common Units owned by him, including, without limitation, the right to receive
distributions made in respect of the Class B Common Units.

                                       4
<PAGE>

         9.       Certain Acknowledgments; Injunctive Relief.

                  (a)      Each Holder acknowledges that the obligations of the
Holders under this Agreement are reasonable and necessary to protect the Company
and its legitimate business interests, notwithstanding any rights, powers or
privileges that may be afforded to Members, whether by law, agreement or
otherwise.

                  (b)      Each Holder further acknowledges and agrees that the
Company will be irreparably harmed and that damages alone cannot adequately
compensate the Company in the event of the breach of any of the obligations of
any Holder under this Agreement, and that injunctive relief against such Holder
is essential for the protection of the Company. Each Holder therefore agrees
that, in addition to any other rights or remedies that the Company may have at
law or in equity, the Company shall be entitled as a matter of right to
injunctive relief in any court of competent jurisdiction, plus attorneys' fees
actually incurred for the securing of such relief, in any proceeding which may
be brought to enforce any provision contained in Section 3 of this Agreement,
without the necessity of proof of actual damages.

         10.      Restrictive Legend. Any certificate issued to a Holder in
respect of Restricted Units shall be registered in the name of such Holder and
shall bear the following (or a similar) legend:

                  "THE VOTING, SALE, TRANSFER, ASSIGNMENT, PLEDGE, HYPOTHECATION
                  OR OTHER ENCUMBRANCE OF THE SECURITIES REPRESENTED BY THIS
                  CERTIFICATE IS SUBJECT TO THE TERMS OF AN EQUITY AND WARRANT
                  AGREEMENT BETWEEN WELLCARE HOLDINGS, LLC AND THE HOLDER OF
                  RECORD OF THIS CERTIFICATE. NO TRANSFER OF THE SECURITIES
                  REPRESENTED BY THIS CERTIFICATE IN CONTRAVENTION OF SUCH
                  AGREEMENT SHALL BE VALID OR EFFECTIVE. COPIES OF SUCH
                  AGREEMENT MAY BE OBTAINED BY WRITTEN REQUEST MADE BY THE
                  HOLDER OF RECORD OF THE CERTIFICATE TO THE SECRETARY OF
                  WELLCARE HOLDINGS, LLC."

         11.      Issuance of New Certificates. To the extent applicable, upon
the lapse of the Restricted Period the Company shall, if requested in writing by
a Holder, issue or have issued new certificates without the legend described in
Section 10 of this Agreement in exchange for those previously issued.

         12.      General.

                  (a)      Notices. All notices, requests and other
communications hereunder must be in writing and will be deemed to have been duly
given only if delivered personally against written receipt or by facsimile
transmission against facsimile confirmation or mailed by internationally
recognized overnight courier prepaid, to the parties at the following addresses
or facsimile numbers:

                                       5
<PAGE>

                  If to any Holder to:

                           c/o Sandip I. Patel, Esq.
                           1408 North Westshore Boulevard, Suite 611
                           Tampa, FL 33607
                           Facsimile No.: (813) 289-8849

                  with a copy to:

                           Foley & Lardner
                           100 North Tampa Street, Suite 2700
                           Tampa, FL 33602-5804
                           Facsimile No.: (813) 221-4210
                           Attention: Martin A. Traber, Esq.

                  If to the Company to:

                           WellCare Holdings, LLC
                           67 East 11th Street, Suite 318
                           New York, NY 10003
                           Facsimile No.: (212) 388-1659
                           Attn: Todd Farha, Chief Executive Officer

                  with a copy to:

                           Brobeck, Phleger & Harrison LLP
                           2100 Reston Parkway, Suite 203
                           Reston, VA 20191
                           Facsimile No.: (703) 621-3001
                           Attention: Thaddeus Bereday, Esq.

                                    and

                           Kirkland & Ellis
                           153 East 53rd Street
                           New York, NY 10022-4675
                           Facsimile No.: (212) 446-4900
                           Attention: W. Brian Raftery, Esq.

All such notices, requests and other communications will (i) if delivered
personally to the address as provided in this Section 12(a), be deemed given
upon delivery, (ii) if delivered by facsimile transmission to the facsimile
number as provided for in this Section 12(a), be deemed given upon facsimile
confirmation, and (iii) if delivered by overnight courier to the address as
provided in this Section 12(a), be deemed given on the earlier of the first
Business Day following the date sent by such overnight courier or upon receipt
(in each case regardless of whether such notice, request or other communication
is received by any other person to whom a copy of such notice is to be delivered
pursuant to this Section 12(a)). Any party from time to time may

                                       6
<PAGE>

change its address, facsimile number or other information for the purpose of
notices to that party by giving notice specifying such change to the other party
hereto.

                  (b)      Entire Agreement. This Agreement constitutes the
entire agreement among the parties with respect to the subject matter hereof and
supersedes all prior agreements and understandings, both written and oral, among
the parties with respect to the subject matter hereof.

                  (c)      Amendments; Waiver. No modification or amendment of
any provision of this Agreement shall be effective unless it is in a writing
signed by the parties hereto. Any term or condition of this Agreement may be
waived at any time by the party that is entitled to the benefit thereof, but no
such waiver shall be effective unless set forth in a written instrument duly
executed by or on behalf of the party waiving such term or condition. No waiver
by any party of any term or condition of this Agreement, in any one or more
instances, shall be deemed to be or construed as a waiver of the same or any
other term or condition of this Agreement on any future occasion. All remedies,
either under this Agreement or by law or otherwise afforded, will be cumulative
and not alternative.

                  (d)      No Assignment; Binding Effect. Except as otherwise
expressly set forth herein, neither this Agreement nor any right, interest or
obligation hereunder may be assigned (by operation of law or otherwise) by any
party hereto without the prior written consent of the other parties hereto and
any attempt to do so will be void. Subject to the preceding sentence, this
Agreement is binding upon, inures to the benefit of and is enforceable by the
parties hereto and their respective successors, heirs and assigns (including any
successor entity to the Company).

                  (e)      Headings. The headings used in this Agreement have
been inserted for convenience of reference only and do not define or limit the
provisions hereof.

                  (f)      Invalid provisions. If any provision of this
Agreement is held to be illegal, invalid or unenforceable under any present or
future law, and if the rights or obligations of any party hereto under this
Agreement will not be materially and adversely affected thereby, (i) such
provision will be fully severable, (ii) this Agreement will be construed and
enforced as if such illegal, invalid or unenforceable provision had never
comprised a part hereof, (iii) the remaining provisions of this Agreement will
remain in full force and effect and will not be affected by the illegal, invalid
or unenforceable provision or by its severance herefrom and (iv) in lieu of such
illegal, invalid or unenforceable provision, there will be added automatically
as a part of this Agreement a legal, valid and enforceable provision as similar
in terms to such illegal, invalid or unenforceable provision as may be possible.

                  (g)      Governing Law. This Agreement shall be governed by
and construed in accordance with the domestic laws of the State of New York,
without giving effect to any choice of law or conflict of law provision or rule
(whether of the State of New York or any other jurisdiction) that would cause
the application of the laws of any jurisdiction other than the State of New
York.

                  (h)      Jurisdiction: Venue. All actions and proceedings
arising out of or relating to this Agreement shall be heard and determined in
any New York state or federal court sitting in

                                       7
<PAGE>

the City of New York, and each party hereby irrevocably accepts and consents to
the exclusive personal jurisdiction of those courts for such purpose. In
addition, each party hereby irrevocably waives, to the fullest extent permitted
by law, any objection which it may now or hereafter have to the laying of venue
of any action or proceeding arising out of or relating to this Agreement or any
judgment entered by any court in respect thereof brought in any state or federal
court sitting in the city of New York and further irrevocably waives any claim
that any action or proceeding brought in any such court has been brought in an
inconvenient forum.

                  (i)      Waiver of Trial by Jury. IN ANY ACTION OR PROCEEDING
ARISING HEREFROM, THE PARTIES HERETO CONSENT TO TRIAL WITHOUT A JURY IN ANY
ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY ANY PARTY HERETO AGAINST THE OTHER
OR THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION
WITH THIS AGREEMENT, REGARDLESS OF THE FORM OF ACTION OR PROCEEDING.

                  (j)      Interpretation. The parties hereto agree that this
Agreement is the product of negotiation between sophisticated parties and
individuals, all of whom were represented by counsel, and each of whom had an
opportunity to participate in and did participate in, the drafting of each
provision hereof. Accordingly, ambiguities in this Agreement, if any, shall not
be construed strictly or in favor of or against any party hereto but rather
shall be given a fair and reasonable construction.

                  (k)      Counterparts. This Agreement may be executed in any
number of counterparts, each of which will be deemed an original, but all of
which together will constitute one and the same instrument.

                            [SIGNATURE PAGE FOLLOWS]

                                       8
<PAGE>

         IN WITNESS WHEREOF, the Company and each of the Holders have executed
this Equity and Warrant Agreement as of the date first written above.

                                       WELLCARE HOLDINGS, LLC

                                       By /s/ Todd Farha
                                          --------------------------------------
                                          Todd Farha
                                          President and Chief Executive Officer

                                       /s/ Kiran C. Patel
                                       -----------------------------------------
                                       Kiran C. Patel, M.D.

                                       /s/ Pradip C. Patel
                                       -----------------------------------------
                                       Pradip C. Patel

                                       /s/ Rupesh Shah
                                       -----------------------------------------
                                       Rupesh Shah

<PAGE>

                                   SCHEDULE A

<TABLE>
<CAPTION>
                                     The Number of Class B Common
                                     Units that such Holders has the right
    Holder                           to purchase pursuant to the Warrants
    ------                           ------------------------------------
<S>                                  <C>
Kiran C. Patel, M.D.                               4,424.045
Pradip C. Patel                                    1,317.333
Rupesh Shah                                        1,119.733

   Total Warrant Units                             6,861.111
</TABLE>

<PAGE>

                                                                       EXHIBIT A

                          NON-RECOURSE PROMISSORY NOTE

_______________ ____, ______                                          $_________

                  [_______] (the "Maker"), for value received, hereby promises
to pay to WellCare Holdings, LLC, a Delaware limited liability company (the
"Company"), the principal amount of [________] on the date Maker (or the heirs,
personal representatives or relatives of Maker) ceases to own any of the
Restricted Units (as herein defined) (the "Maturity Date").

                  Pursuant to an Equity and Warrant Agreement, dated as of
________ ___, 2002 (the "Equity and Warrant Agreement"), between the Maker, the
Company and the other parties named therein, the Maker has exercised certain of
the Warrants (as such term is defined in the Equity and Warrant Agreement) and
purchased [_______] Class B Common Units (as herein defined) (the "Purchased
Units"). As permitted by the Equity and Warrant Agreement, the Maker has issued
this Note to the Company as payment of the applicable Exercise Price (as such
term is defined in the Equity and Warrant Agreement) by the Maker for the
Purchased Units.

                  1.       DEFINITIONS. For purposes of this Note, the following
capitalized terms have the following meaning:

                  "Class B Common Units" means the Company's Class B Common
Units (as such term is defined in the LLC Agreement).

                  "LLC Agreement" means the Company's Amended and Restated
Limited Liability Company Agreement, dated as of ______ ___, 2002, as amended
from time to time.

                  "Restricted Units" shall have the meaning given to such term
in the Equity and Warrant Agreement, and shall include the Purchased Units.

                  2.       PAYMENT OF PRINCIPAL.

                  (a)      SCHEDULED PAYMENT. The Maker will pay the entire
unpaid principal amount of this Note on the Maturity Date.

                  (b)      OPTIONAL PREPAYMENT. Subject to Section 3 hereof, the
Maker may prepay the principal amount of this Note, in whole or in any $1,000
increment, at any time and from time to time.

                  (c)      MANDATORY PREPAYMENTS.

                  (i)      Until such time as the principal amount of this Note
         is paid in full, if at any time any holder of Restricted Units
         originally held by the Maker sells or otherwise transfers any such
         Restricted Units, then, on the date of the consummation of such sale or
         transfer, the Maker shall be obligated, to the extent the Maker has
         obligations to the

<PAGE>

         Company (or any of its successors) under this Note, to pay to the
         Company (or such successor) an amount equal to the gross proceeds
         received by such holder for the Restricted Units sold or otherwise
         transferred and such amount paid to the Company shall reduce the
         principal amount of this Note.

                  (ii)     Until such time as the principal amount of this Note
         is paid in full, if the Company (or any of its successors) pays any
         distributions or dividends with respect to any Restricted Units
         originally held by the Maker, then, such distributions or dividends, as
         the case may be, shall be paid to the Company (or such successor)
         rather than to the holders of such Restricted Units, and such amount
         paid to the Company (or such successor) shall reduce the principal
         amount of this Note. Notwithstanding the foregoing, Tax Advances (as
         such term is defined in the LLC Agreement) distributed under Section
         7.3 of the LLC Agreement shall not be applied to reduce the principal
         amount of this Note.

                  3.       INTEREST. No interest shall accrue on this Note.

                  4.       EVENTS OF DEFAULT.

                  (a)      DEFINITION. An "Event of Default" will be deemed to
have occurred if the Maker fails to pay any amount of the principal on this Note
as and when required pursuant to the terms hereof.

                  (b)      CONSEQUENCES OF EVENTS OF DEFAULT.

                  (i)      If an Event of Default has occurred, then the
         aggregate principal amount of this Note will become immediately due and
         payable without any action on the part of the Company.

                  (ii)     Notwithstanding anything to the contrary contained
         herein, the Company's sole remedy in the event of an Event of Default
         is to collect amounts due to the Company pursuant to Sections 2(c)
         hereof, and except for payment obligations pursuant to Sections 2(c)
         hereof, the Maker shall have no liabilities to the Company pursuant to
         this Note.

                  5.       AMENDMENT AND WAIVER. None of the terms or provisions
of this Note may be altered, modified or amended except by an instrument in
writing, duly executed by the Company and the Maker. The Company shall not by
any act, delay, omission or otherwise be deemed to have waived any of its rights
or remedies hereunder, and no waiver shall be valid unless in writing, signed by
the Company, and then only to the extent therein set forth. A waiver by the
Company of any right or remedy hereunder on any one occasion shall not be
construed as a bar to any right or remedy which the Company would otherwise have
on any future occasion. No failure to exercise nor any delay in exercising on
the part of the Company, any right, power or privilege hereunder shall preclude
any other or further exercise thereof or the exercise of any other right, power
or privilege. The rights and remedies herein provided are cumulative and may be
exercised singly or concurrently, and are not exclusive of any rights or
remedies provided by law.

                                       2
<PAGE>

                  6.       CANCELLATION. After all principal at any time owed on
this Note have been paid in full, this Note will be surrendered to the Maker for
cancellation.

                  7.       PAYMENTS. All cash payments to be made to the Company
will be made in the lawful money of the United States of America in immediately
available funds. Payments of principal in respect of this Note will be delivered
to the Company at the Company's chief executive office.

                  8.       DESCRIPTIVE HEADINGS; GOVERNING LAW. The descriptive
headings of the several Sections of this Note are inserted for convenience only
and do not constitute a part of this Note. This Note shall be governed by and
construed in accordance with the laws of the state of New York, without giving
effect to any rules, principles or provisions of choice of law or conflict of
laws.

                  9.       BUSINESS DAYS. If any payment is due, or any time
period for giving notice or taking action expires, on a day which is a Saturday,
Sunday or legal holiday in the State of New York, then the payment will be due
and payable on, and the time period will automatically be extended to, the next
business day immediately following such Saturday, Sunday or legal holiday.

                  10.      SEVERABILITY. If any provision of this Note is held
by any court of competent jurisdiction to be illegal, void or unenforceable,
such provision will be of no force and effect, but such holding shall have no
effect upon the enforceability of any other provision.

                  11.      GENERAL. This Note:

                  (a)      constitutes the entire agreement among the parties
with respect to the subject matter hereof;

                  (b)      supersedes any and all prior understandings relating
to such subject matter; and

                  (c)      will be binding upon and inure to the benefit of the
parties and their respective heirs, executors, administrators, successors and
assigns.

                  12.      WAIVER OF JURY TRIAL. THE MAKER (AND, BY ITS
ACCEPTANCE OF THIS NOTE, THE COMPANY) HEREBY WAIVES, TO THE EXTENT PERMITTED BY
APPLICABLE LAW, TRIAL BY JURY IN ANY LITIGATION IN ANY COURT WITH RESPECT TO, IN
CONNECTION WITH, OR ARISING OUT OF THIS NOTE OR THE VALIDITY, PROTECTION,
INTERPRETATION, COLLECTION OR ENFORCEMENT THEREOF.

                                      *****

                                       3
<PAGE>

                  IN WITNESS WHEREOF, the Maker has executed and delivered this
Non-Recourse Promissory Note as of the date specified above.

                                                 _______________________________
                                                 [MAKER]<PAGE>

                                                                    EXHIBIT 10.9

                            INVESTOR RIGHTS AGREEMENT

         This Investor Rights Agreement (this "Agreement") is made and entered
into AS of July 31, 2002, by and among Wellcare Holdings, LLC, a Delaware
limited liability company (the "Company"), and Kiran C. Patel, M.D., Pradip C.
Patel and Rupesh Shah, each a resident of the State of Florida (each an
"Investor" and collectively the "Investors").

                                    RECITALS

         A.       Pursuant to that certain Purchase Agreement, dated as of May
17, 2002 (the "Purchase Agreement"), by and among Well Care HMO, Inc.,
HealthEase of Florida, Inc., Comprehensive Health Management, Inc.,
Comprehensive Health Management of Florida, L.C. (collectively, the "Well Care
Group"), the Company, the Investors and the other parties named therein, each of
the Investors is being transferred warrants to purchase Class B Common Units (as
herein defined) as set forth therein as partial consideration for the sale of
such Investor's shares of capital stock of and/or other equity securities in the
Well Care Group.

         B.       The execution and delivery of this Agreement by the Company is
a condition precedent to the obligations of the Investors and the Company to
consummate the transactions contemplated by the Purchase Agreement.

         NOW, THEREFORE, in consideration of the covenants and promises set
forth herein, and for other good and valuable consideration (the receipt and
sufficiency of which are hereby acknowledged by the parties), intending to be
legally bound hereby, the parties agree as follows:

                                    ARTICLE 1
                               CERTAIN DEFINITIONS

         As used in this Agreement, the following terms shall have the following
respective meanings:

         "Class A Common Units" means the Company's Class A Common Units (as
such term is defined in the LLC Agreement).

         "Class B Common Units" means the Company's Class B Common Units (as
such term is defined in the LLC Agreement).

         "Class C Common Units" means the Company's Class C Common Units (as
such term is defined in the LLC Agreement).

         "Commission" means the Securities and Exchange Commission or any other
federal agency at the time administering the Securities Act.

<PAGE>

         "Common Units" means collectively, the Class A Common Units, Class B
Common Units, Class C Common Units and any other equity of the Company (or its
successors) hereafter authorized which is not limited to a fixed sum or
percentage of par value or stated value in respect to the rights of the holders
thereof to participate in dividends or other distributions or in the
distribution of assets upon any voluntary or involuntary liquidation,
dissolution or winding up of the issuer of such securities, including any common
equity securities of any successor entity of the Company issued pursuant to a
transaction of the type described in Section 12.16 of the LLC Agreement.

         "Company" is as defined in the preamble hereof, and shall also include
any affiliate or subsidiary of the Company in which the Investors are issued
equity securities pursuant to Section 12.16 of the LLC Agreement.

         "Equity and Warrant Agreement" means the Equity and Warrant Agreement,
dated AS of the date hereof, by and among the Company and the Investors.

         "Exchange Act" means the Securities Exchange Act of 1934, as amended,
or any similar federal rule or statute and the rules and regulations of the
Commission thereunder, all as the same shall be in effect at the time.

         "Form S-3" means such form under the Securities Act as is in effect on
the date hereof or any successor registration form under the Securities Act
subsequently adopted by the Commission that permits inclusion or incorporation
of substantial information by reference to other documents filed by the Company
with the Commission.

         "Holder" means any Investor holding Registrable Securities.

         "Initial Public Offering" shall mean the initial public offering of
equity securities of the Company or any of its subsidiaries or affiliates, as
described in Section 12.16 of the LLC Agreement.

         "Investor Non-Recourse Promissory Note" means any non-recourse
promissory note issued by any Investor or any other holder of a Warrant to the
Company as payment of any or all of the Exercise Price (as such term is defined
in the Equity and Warrant Agreement).

         "LLC Agreement" shall mean the Amended and Restated Limited Liability
Company Agreement of the Company, dated as of the date hereof, as amended from
time to time.

         "New Securities" shall mean any Units of the Company, including Common
Units and any series of Preferred Units, whether now authorized or not, and
rights, options or warrants to purchase said Common Units or Preferred Units,
and securities of any type whatsoever that are, or may become, convertible into
or exchangeable for said Common Units or Preferred Units; provided, however,
that such term shall not include Units issued or issuable: (i) upon conversion
of Preferred Units; (ii) to employees, officers, directors or consultants of the
Company or any of its subsidiaries pursuant to any stock or unit option, stock
or unit grant, stock or unit purchase or similar plans and/or arrangements, the
primary purpose of which are not to raise additional equity capital for the
Company; (iii) in connection with equipment leasing arrangements, bank or

                                        2
<PAGE>

other institutional loans, other debt financing arrangements, acquisitions of
product lines or other arrangements or transactions, the principal purpose of
which is other than equity, convertible debt, or equity equivalent financing;
(iv) as a stock or unit split, dividend, distribution or a recapitalization or
reorganization of the Company; (v) in an Initial Public Offering or otherwise in
a transaction of the type described in Section 12.16 of the LLC Agreement; (vi)
as direct consideration for the acquisition by the Company or any of its
subsidiaries of all or substantially all of the stock, equity or assets of any
other entity or the merger of any other entity with or into the Company or any
of its subsidiaries; (vii) if the holders of not less than a majority of the
then outstanding number of Registrable Securities agree in writing that such
Units shall not constitute New Securities; or (viii) upon exercise of warrants
or options, or upon the conversion of convertible securities.

         "Preferred Units" means the Company's Preferred Units (as such term is
defined in the LLC Agreement).

         The "Pro Rata Share" of an Investor shall equal the proportion that the
total number of Common Units then held by such Investor plus the number of
Common Units issuable upon conversion of any Preferred Units then held by such
Investor bears to the sum of the total number of Common Units then outstanding
plus the number of Common Units issuable upon exercise or conversion of all then
outstanding securities exercisable for or convertible into, directly or
indirectly, Common Units. For purposes of this definition, all Warrants shall be
deemed exercised and the Class B Common Units issuable upon exercise of such
Warrants shall be deemed issued and outstanding.

         "Registrable Securities" means (i) the Common Units issued to the
Investors pursuant to the Purchase Agreement, (ii) any Common Units issued or
issuable in respect of any of the foregoing upon any stock or unit split, stock
or unit dividend or distribution, recapitalization or similar event and (iii)
any common stock or other common equity securities issued to the Investors in
connection with a transaction described in Section 12.16 of the LLC Agreement;
provided, however, that securities shall only be treated as Registrable
Securities if and so long as (x) they have not been registered or sold to or
through a broker or dealer or underwriter in a public distribution or a public
securities transaction and (y) the registration rights with respect to such
securities have not terminated pursuant to Section 2.7. For purposes of this
definition, all Warrants shall be deemed exercised and the Class B Common Units
issuable upon exercise of such Warrants shall be deemed issued and outstanding.

         The terms "register," "registered" and "registration" refer to a
registration effected by preparing and filing a registration statement in
compliance with the Securities Act, and the declaration or ordering of the
effectiveness of such registration statement.

         "Registration Expenses" shall mean all expenses, except as otherwise
stated below, incurred by the Company in complying with Section 2.1 hereof,
including without limitation, all registration, qualification and filing fees,
printing expenses, escrow fees, fees and disbursements of counsel for the
Company, blue sky fees and expenses, the expense of any special audits incident
to or required by any such registration (but excluding the Selling Expenses).

                                        3
<PAGE>

         "Rule 144" and "Rule 145" shall mean Rules 144 and 145, respectively,
promulgated under the Securities Act, or any similar federal rules thereunder,
all as the same shall be in effect at the time.

         "Securities Act" shall mean the Securities Act of 1933, as amended, or
any similar federal rule or statute and the rules and regulations of the
Commission thereunder, all as the same shall be in effect at the time.

         "Selling Expenses" shall mean all underwriting discounts, selling
commissions and stock transfer taxes applicable to the securities registered by
the Holders and all fees and disbursements of counsel for any Holder.

         "Senior Securityholders" shall mean any person or entity which, on the
date hereof or at any time hereafter, owns any Class A Common Units, Preferred
Units or any New Securities deemed by their terms or by any agreement binding on
the Company to be senior in right of registration to the Registrable Securities.

         "Units" means the Company's Units (as such term is defined in the LLC
Agreement).

         "Warrants" shall mean the Warrants (as such term is defined in the
Equity and Warrant Agreement).

                                    ARTICLE 2
                                  REGISTRATION

         2.1      Company Registration.

                  (a)      Notice OF Registration. If at any time or from time
to time following the closing of an Initial Public Offering, the Company shall
determine to register any of its equity securities, either for its own account
or the account of a Holder or other holders, other than a registration relating
solely to employee benefit plans, a registration relating solely to a Rule 145
transaction or a registration in which the only equity security being registered
is Common Units issuable upon conversion of convertible debt securities which
are also being registered, the Company will:

                           (i)      give to each Holder written notice thereof
in writing at least 20 days prior to filing any registration statement; and

                           (ii)     subject to subsection (b) below, include in
such registration (and any related qualifications including compliance with Blue
Sky laws), and in any underwriting involved therein, all the Registrable
Securities specified in a written request or requests, made within 15 days after
the date of such written notice from the Company, by any Holder.

                  (b)      Underwriting. If the registration of which the
Company gives notice is for a registered public offering involving an
underwriting, the Company shall so advise the Holders as a part of the written
notice given pursuant to Section 2.1(a)(i). In such event, the right of any
Holder to registration pursuant to this Section 2.1 shall be conditioned upon
such Holder's

                                        4
<PAGE>

participation in such underwriting and the inclusion of Registrable Securities
in the underwriting shall be limited to the extent provided herein. All Holders
proposing to distribute their securities through such underwriting shall
(together with the Company and the other equityholders distributing their
securities through such underwriting) enter into an underwriting agreement in
customary form with the managing underwriter selected for such underwriting by
the Company. Notwithstanding any other provision of this Section 2.1, if the
managing underwriter determines that marketing factors require a limitation of
the number of shares to be underwritten, the managing underwriter may limit the
Registrable Securities to be included in such registration to zero; provided
that the Company shall ensure that the number of shares included in such
registration shall be allocated as follows: (i) first, to the Company, (ii)
second, to the Senior Securityholders, on a pro rata basis based on the total
number of shares subject to registration rights held by all such Senior
Securityholders, and (5) third, to the Holders and holders of any other Common
Units requested to be included in such registration by equityholders entitled to
registration rights in connection therewith, on a pro rata basis based upon the
number of shares subject to registration rights held by each such Holder or
other equityholder. To facilitate the allocation of shares in accordance with
the above provisions, the Company or the underwriters may round the number of
shares allocated to any Holder to the nearest 100 shares. If any Holder
disapproves of the terms of any such underwriting, such person may elect to
withdraw therefrom by written notice to the Company.

                  (c)      Right to Terminate Registration. The Company shall
have the right to terminate or withdraw any registration initiated by it under
this Section 2.1 prior to the effectiveness of such registration whether or not
any Holder has elected to include securities in such registration.

                  (d)      Form S-3 Registration. In case the Company shall
receive from one or more Holders a written request or requests that the Company
effect a registration on Form S-3 and any related qualification or compliance
with respect to all or a part of the Registrable Securities owned by such
Holders, provided the number of shares requested to be sold would have an
aggregate price to the public of at least $1,000,000, then the Company will:

                           (i)      Promptly give written notice of the proposed
registration and the Holder's request therefor, and any related qualification or
compliance, to all other Holders of Registrable Securities; and

                           (ii)     As soon as practicable, use commercially
reasonable efforts to effect such registration and all such qualifications and
compliances as may be so requested and as would permit or facilitate the sale
and distribution of all or such portion of the Holder's Registrable Securities
as are specified in such request together with all or such portion of the
Registrable Securities of any Holder or Holders joining in such request as are
specified in a written request received by the Company within 15 days after
written notice from the Company is given under Section 2.1(d)(i) above;
provided, however, that the Company shall not be obligated to effect any such
registration, qualification or compliance pursuant to this Section 2.1(d):

                                    (A)      if Form S-3 is not available for
such offering by the Holders;

                                        5
<PAGE>

                                    (B)      if the Company shall furnish to the
Holders a certificate signed by the President or Chief Executive Officer of the
Company stating that in the good faith judgment of the Board of Directors of the
Company, it would require the disclosure of material information that the
Company has a bona fide business purpose to maintain as confidential or be
seriously detrimental to the Company and its equityholders for such Form S-3
registration to be effected at such time, in which event the Company shall have
the right to defer the filing of the Form S-3 registration statement for an
aggregate of not more than 90 days after receipt of the request of the Holders;
provided, however, that the Company may not utilize this right more than once in
any twelve-month period;

                                    (C)      in any particular jurisdiction in
which the Company would be required to qualify to do business or to execute a
general consent to service of process in effecting such registration,
qualification or compliance; or

                                    (D)      more than once in any twelve-month
period.

Subject to the foregoing, the Company shall use commercially reasonable efforts
to file a Form S-3 registration statement covering Registrable Securities and
other securities so requested to be registered pursuant to this Section 2.1(d)
as soon as practicable after receipt of the request of the Holders for such
registration.

         2.2      Expenses of Registration. All Registration Expenses incurred
in connection with all registrations pursuant to Section 2.1(a) shall be borne
by the Company. All Registration Expenses incurred in connection with all
registrations pursuant to Section 2.1(d) shall be borne pro rata by the Holders
participating in such registrations. All Selling Expenses relating to securities
registered on behalf of the Holders shall be borne by the Holders of such
securities pro rata on the basis of the number of shares so registered or
proposed to be so registered.

         2.3      Registration Procedures. In the case of each registration
effected by the Company pursuant to this Agreement, the Company will keep each
Holder advised in writing as to the initiation of such registration and as to
the completion thereof. The Company will:

                  (a)      Prospectus. Furnish to the Holders such number of
copies of a prospectus, including a preliminary prospectus, in conformity with
the requirements of the Securities Act, and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable
Securities owned by them.

                  (b)      Notice. Notify each Holder of Registrable Securities
covered by such registration statement at any time when a prospectus relating
thereto is required to be delivered under the Securities Act of the happening of
any event as a result of which the prospectus included in such registration
statement, as then in effect, includes an untrue statement of a material fact or
omits to state a material fact required to be stated therein or necessary to
make the statements therein not misleading in light of the circumstances then
existing. The Company will use reasonable efforts to amend or supplement such
prospectus in order to cause such prospectus not to include any untrue statement
of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading in the light
of the circumstances then existing.

                                       6
<PAGE>

                  (c)      Listing. Cause all such Registrable Securities
registered pursuant hereto to be listed on each securities exchange or automated
quotation system on which similar securities issued by the Company are then
listed.

                  (d)      Transfer Agent; CUSIP Number. Provide a transfer
agent and registrar for all Registrable Securities registered pursuant hereunder
and a CUSIP number for all such Registrable Securities not later than the
effective date of such registration.

                  (e)      Blue Sky. Use commercially reasonable efforts to
register and qualify the securities covered by such registration statement under
such other securities or Blue Sky laws of such jurisdictions as shall be
reasonably requested by the Holders, provided, however, that the Company shall
not be required in connection therewith or as a condition thereto to qualify to
do business or to file a general consent to service of process in any such
states or jurisdictions.

                  (f)      Underwriting Agreement. In the event of any
underwritten public offering, enter into and perform its obligations under an
underwriting agreement, in usual and customary form, with the managing
underwriter(s) of such offering. Each Holder participating in such underwriting
shall also enter into and perform its obligations under such an agreement.

                  (g)      Opinion; Comfort Letter. In the event of any
underwritten public offering, furnish, at the request of any Holder registering
Registrable Securities, on the date that such Registrable Securities are
delivered to the underwriters for sale, (i) an opinion, dated as of such date,
of the counsel representing the Company for the purposes of such registration,
in form and substance as is customarily given to underwriters in an underwritten
public offering addressed to the underwriters; and (ii) a "comfort" letter dated
as of such date, from the independent certified public accountants of the
Company, in form and substance as is customarily given by independent certified
public accountants to underwriters.

         2.4      Indemnification.

                  (a)      Company Indemnification. The Company will indemnify
each Holder, each of its officers and directors and partners, any underwriter
for such Holder, and each person controlling such Holder within the meaning of
Section 15 of the Securities Act, with respect to which registration has been
effected pursuant to this Agreement, against all expenses, claims, losses,
damages or liabilities (or actions in respect thereof), including any of the
foregoing incurred in settlement of any litigation, commenced or threatened,
arising out of or based on any untrue statement (or alleged untrue statement) of
a material fact contained or incorporated by reference in any registration
statement, prospectus, offering circular or other document, or any amendment or
supplement thereto, incident to any such registration, or based on any omission
(or alleged omission) to state therein a material fact required to be stated
therein or necessary to make the statements therein, in light of the
circumstances in which they were made, not misleading, or any violation by the
Company of the Securities Act, the Exchange Act, state securities laws or any
rule or regulation promulgated under such laws applicable to the Company in
connection with any such registration, and the Company will reimburse each such
Holder, each of its officers and directors, and each person controlling such
Holder, for any legal and any other expenses reasonably incurred, as such
expenses are incurred, in connection with investigating, preparing or defending
any such claim, loss, damage, liability or action; provided,

                                        7
<PAGE>

however, that the Company will not be liable in any such case to the extent that
any such claim, loss, damage, liability or expense arises out of or is based on
any untrue statement or omission or alleged untrue statement or omission, made
in reliance upon and in conformity with any information furnished to the Company
by such Holder or controlling person in writing and expressly stated for use in
connection with such registration; and provided, further, that the indemnity
agreement contained in this Section 2.4(a) shall not apply to amounts paid in
settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the prior written consent of the Company (which
consent shall not be unreasonably withheld).

                  (b)      Holder Indemnification. Each Holder will, if
Registrable Securities held by such Holder are included in the securities as to
which such registration is being effected, indemnify the Company, each of its
directors and officers, other holders of the Company's securities being sold
under such registration statement, each person who controls the Company within
the meaning of Section 15 of the Securities Act, and each other such Holder,
each of its officers and directors and each person controlling such Holder
within the meaning of Section 15 of the Securities Act, against all claims,
losses, damages and liabilities (or actions in respect thereof) arising out of
or based on any untrue statement (or alleged untrue statement) of a material
fact contained in any such registration statement, prospectus, offering circular
or other document, or any omission (or alleged omission) to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, or any violation by the Holder of the Securities Act,
the Exchange Act, state securities laws or any rule or regulation promulgated
under such laws applicable to the Holder, and will reimburse the Company, such
other Holders, such directors, officers, persons, underwriters or control
persons for any legal or any other expenses reasonably incurred, as such
expenses are incurred, in connection with investigating or defending any such
claim, loss, damage, liability or action, but in the case of the Company or the
other Holders or their officers, directors or controlling persons, only to the
extent that such untrue statement (or alleged untrue statement) or omission (or
alleged omission) is made in such registration statement, prospectus, offering
circular or other document in reliance upon and in conformity with any
information furnished to the Company by such Holder in writing and expressly
stated for use in connection with such registration; provided, however, that the
indemnity agreement contained in this subsection 2.4(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the prior consent of the Holder (which
consent shall not be unreasonably withheld); and provided, further, that the
total amounts payable in indemnity by a Holder under this Section 2.4(b) in
respect of any violation shall not exceed the net proceeds received by such
Holder in the registered offering out of which such violation arises.

                  (c)      Notice. Each party entitled to indemnification under
this Section 2.4 (the "Indemnified Party") shall give notice to the party
required to provide indemnification (the "Indemnifying Party") promptly after
such Indemnified Party has actual knowledge of any claim as to which indemnity
may be sought, and shall permit the Indemnifying Party to assume the defense of
any such claim or any litigation resulting therefrom, provided that counsel for
the Indemnifying Party, who shall conduct the defense of such claim or
litigation, shall be approved by the Indemnified Party (whose approval shall not
unreasonably be withheld), and the Indemnified Party may participate in such
defense at such party's expense, and provided further

                                        8
<PAGE>

that the failure of any Indemnified Party to give notice as provided herein
shall not relieve the Indemnifying Party of its obligations under this Agreement
unless the failure to give such notice is materially prejudicial to an
Indemnifying Party's ability to defend such action and provided further, that
the Indemnifying Party shall not assume the defense for matters as to which
there is a conflict of interest or there are separate and different defenses. No
Indemnifying Party, in the defense of any such claim or litigation, shall,
except with the consent of each Indemnified Party (whose consent shall not be
unreasonably withheld), consent to entry of any judgment or enter into any
settlement which does not include as an unconditional term thereof the giving by
the claimant or plaintiff to such Indemnified Party of a release from all
liability in respect to such claim or litigation.

                  (d)      Contribution. If the indemnification provided for in
this Section 2.4 is held by a court of competent jurisdiction to be unavailable
to an indemnified party with respect to any losses, claims, damages or
liabilities referred to herein, the indemnifying party, in lieu of indemnifying
such indemnified party thereunder, shall to the extent permitted by applicable
law contribute to the amount paid or payable by such indemnified party as a
result of such loss, claim, damage or liability in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one
hand and of the indemnified party on the other in connection with the untrue
statement or omission that resulted in such loss, claim, damage or liability, as
well as any other relevant equitable considerations. The relative fault of the
indemnifying party and of the indemnified party shall be determined by a court
of law by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and
the parties' relative intent, knowledge, access to information and opportunity
to correct or prevent such statement or omission.

                  (e)      Survival. The obligations of the Company and Holders
under this Section 2.4 shall survive completion of any offering of Registrable
Securities in a registration statement and the termination of this agreement.
The provisions of this Section 2.4 shall survive any termination of this
Agreement.

                  (f)      Conflict with Underwriting Agreement. Notwithstanding
the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection
with the underwritten public offering are in conflict with the foregoing
provisions, the provisions in the underwriting agreement shall control.

         2.5      Information by Holder. The Holder or Holders of Registrable
Securities included in any registration shall furnish to the Company such
information regarding such Holder or Holders, the Registrable Securities held by
them and the distribution proposed by such Holder or Holders as shall be
reasonably required in connection with any registration referred to in this
Agreement.

         2.6      Lock-Up Agreement. Each Holder hereby agrees that, in
connection with an Initial Public Offering, if so requested by the Company or
any representative of the underwriters (the "Managing Underwriter"), such Holder
or transferee shall not, directly or indirectly, sell, offer to sell, contract
to sell (including, without limitation, any short sale, but excluding any donees
of the Holder who agree to be similarly bound), grant any option to purchase or

                                        9
<PAGE>

otherwise transfer or dispose of any securities of the Company during the period
specified by the Company's Board of Directors at the request of the Managing
Underwriter (the "Market Standoff Period"), with such period not to exceed 180
days following the effective date of a registration statement of the Company
filed under the Securities Act; provided, however, that each officer and
director of the Company who owns Common Units and each holder of at least 5% of
the then outstanding Common Units also agrees to such restrictions. The Company
may impose stop-transfer instructions with respect to securities subject to the
foregoing restrictions until the end of such Market Standoff Period.

         2.7      Termination of Registration Rights. The rights granted
pursuant to Section 2.1 of this Agreement shall terminate as to any Holder upon
the earlier of (i) the date two years after the effective date of an Initial
Public Offering and (ii) the date such Holder is able to immediately sell all
Registrable Securities held by such Holder under Rule 144 during any 90-day
period.

         2.8      Rule 144 Reporting. With a view to making available the
benefits of certain rules and regulations of the Commission which may at any
time permit the sale of the Registrable Securities to the public without
registration, after such time as a public market exists for the Common Units of
the Company, the Company agrees to:

                  (a)      Make and keep public information available, as those
terms are understood and defined in Rule 144 under the Securities Act, at all
times after the effective date of the first registration under the Securities
Act filed by the Company for an offering of its securities to the general
public;

                  (b)      Use commercially reasonable efforts to file with the
Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act (at any time after it has
become subject to such reporting requirements); and

                  (c)      So long as a Holder owns any Registrable Securities,
to furnish to the Holder forthwith upon written request a written statement by
the Company as to its compliance with the reporting requirements of Rule 144 (at
any time after 90 days after the effective date of the first registration
statement filed by the Company for an offering of its securities to the general
public), and of the Securities Act and the Exchange Act (at any time after it
has become subject to the reporting requirements of the Exchange Act), a copy of
the most recent annual or quarterly report of the Company, and such other
reports and documents of the Company as a Holder may reasonably request in
writing in availing itself of any rule or regulation of the Commission allowing
a Holder to sell any such securities without registration (at any time after the
Company has become subject to the reporting requirements of the Exchange Act).

                                    ARTICLE 3
                             RIGHT OF PARTICIPATION

         3.1      Right of Participation. Subject to the terms and conditions
specified in this Article 3, the Company hereby grants to each Investor a right
of first offer to purchase its Pro Rata Share of New securities which the
Company may from time to time propose to sell and issue, as follows:

                                       10
<PAGE>

                  (a)      The Company shall deliver a written notice (the
"Notice") to the Investor stating (i) its bona fide intention to issue and sell
New Securities, (ii) the number and type of such New Securities and (iii) the
price and terms upon which it proposes to issue such New Securities.

                  (b)      By written notification received by the Company
within 15 days after the giving of the Notice, the Investor may elect to
purchase, at the price and on the terms specified in the Notice, up to its
respective Pro Rata Share of such New Securities.

                  (c)      Beginning 15 days after the date of the Notice, the
Company shall have 120 days to sell the New Securities not elected or eligible
to be purchased by the Investors, at a price and upon terms no more favorable to
the purchasers of such securities than specified in the Notice. In the event
that the Company has not sold all of the New Securities within such 120 day
period, the Company shall not thereafter issue or sell any New Securities
without first offering such securities in accordance with this Section 3.1.

         3.2      Termination. Notwithstanding anything to the contrary
contained herein, the provisions of this Article 3 will terminate and be of no
further force or effect upon the closing of an Initial Public Offering.

                                    ARTICLE 4
                               INFORMATION RIGHTS

         4.1      Financial and Certain Other Information. The Company will
provide the following documents to each Investor:

                  (a)      Annual Reports. As soon as practicable after the end
of each fiscal year, and in any event within 120 days after the end of each such
fiscal year, consolidated balance sheets of the Company and its subsidiaries, if
any, as of the end of such fiscal year, and consolidated statements of
operations and consolidated statements of cash flows and members' or
stockholders' equity of the Company and its subsidiaries, if any, for such year,
prepared in accordance with generally accepted accounting principles and setting
forth in each case in comparative form the figures for the previous fiscal year,
all in reasonable detail and audited by independent public accountants of
national standing selected by the Company.

                  (b)      Quarterly Reports. As soon as practicable after the
end of the first, second and third quarterly accounting periods in each fiscal
year of the Company and in any event within 45 days thereafter, a consolidated
balance sheet of the Company and its subsidiaries, if any, as of the end of each
such quarterly period, and consolidated statements of operations and
consolidated statements of cash flows of the Company and its subsidiaries, if
any, for such period and for the current fiscal year to date, prepared in
accordance with generally accepted accounting principles (other than
accompanying notes), subject to changes resulting from year-end audit
adjustments, in reasonable detail and signed by the principal financial or
accounting officer of the Company.

                                       11
<PAGE>

                  (c)      Material Litigation. As soon as practicable but in
any event within five days after receiving the applicable service of process, a
copy of any lawsuit filed against the Company which alleges damages in excess of
$5 million.

                  (d)      Tax and Organizational Documents.

                           (i)      A copy of the Company's Federal Income Tax
Form 1065 for each calendar year as soon as practicable (and in any event within
14 days) after the filing of such Form 1065 with the Internal Revenue Service;

                           (ii)     A copy of any amendment to the Company's
Certificate of Formation or Limited Liability Company Agreement, as soon as
practicable (and in any event within 14 days) after the effectiveness of any
such amendment; and

                           (iii)    An updated copy of the Company's Members
Schedule (as such term is defined in the LLC Agreement), as soon as practicable
(and in any event within 14 days) after any material change thereto.

         4.2      Confidentiality. Each Investor acknowledges and agrees that
any information obtained pursuant to this Section 4 which may be considered
nonpublic information will be maintained in confidence by such Investor and will
not be utilized by such Investor in connection with purchases or sales of the
Company's securities except in compliance with applicable state and federal
securities laws.

         4.3      Termination. The covenants of the Company set forth in this
Article 4 shall terminate and be of no further force or effect upon the closing
of an Initial Public Offering.

                                    ARTICLE 5
                                    COVENANTS

         5.1      Initial Public Offering of the Company. The Company shall not
consummate a registered initial public offering of its equity securities without
the prior written consent of the Investors; provided, that, notwithstanding the
foregoing, in no event shall the consent of the Investors be required for any
direct or indirect subsidiary of the Company to consummate a registered public
offering of such subsidiary's equity securities. If at any time the Warrants
have been exercised in full and there are no issued and outstanding Investor
Non-Recourse Promissory Notes, then this Section 5.1 shall terminate.

         5.2      Fair Market Value of any Investor Non-Recourse Promissory
Notes. The Company and the Investors hereby agree that, under all circumstances
and at all times, including for purposes of the LLC Agreement, any Investor
Non-Recourse Promissory Note shall be deemed to have a "Fair Market Value" equal
to the then outstanding principal amount on such Investor Non-Recourse
Promissory Note, and no party hereto shall take any position to the contrary.

                                       12
<PAGE>

                                    ARTICLE 6
                            MISCELLANEOUS PROVISIONS

         6.1      Termination. Notwithstanding anything to the contrary
contained in this Agreement, the rights of each Holder under this Agreement
shall automatically terminate on the date that such Holder no longer owns any
Registrable Securities.

         6.2      Notices. All notices, requests and other communications
hereunder must be in writing and will be deemed to have been duly given only if
delivered personally against written receipt or by facsimile transmission
against facsimile confirmation or mailed by internationally recognized overnight
courier prepaid, to the parties at the following addresses or facsimile numbers:

         If to the Company to:        WellCare Holdings, LLC
                                      67 East 11th Street, Suite 318
                                      New York, NY 10003
                                      Facsimile No.: (212) 388-1659
                                      Attn: Todd Farha, Chief Executive Officer

         with A copy to:              Brobeck, Phleger & Harrison LLP
                                      2100 Reston Parkway, Suite 203
                                      Reston, VA 20191
                                      Facsimile No.: (703) 621-3001
                                      Attn: Thaddeus Bereday, Esq.

                                               and

                                      Kirkland & Ellis
                                      153 East 53rd Street
                                      New York, NY 10022-4675
                                      Facsimile No.: (212) 446-4900
                                      Attn: W. Brian Raftery, Esq.

         If to the Investors to:      c/o Sandip I. Patel, Esq.
                                      1408 North Westshore Boulevard, Suite 611
                                      Tampa, FL 33607
                                      Facsimile No.: (813) 289-8849

         with a copy to:              Foley & Lardner
                                      100 North Tampa Street, Suite 2700
                                      Tampa, FL 33602-5804
                                      Facsimile No.: (813) 221-4210
                                      Attn: Martin A. Traber, Esq.

All such notices, requests and other communications will (a) if delivered
personally to the address as provided in this Section 5.2, be deemed given upon
delivery, (b) if delivered by facsimile transmission to the facsimile number as
provided for in this Section 5.2, be deemed

                                       13
<PAGE>

given upon facsimile confirmation, and (c) if delivered by overnight courier to
the address as provided in this Section 5.2, be deemed given on the earlier of
the first business day following the date sent by such overnight courier or upon
receipt (in each case regardless of whether such notice, request or other
communication is received by any other person to whom a copy of such notice is
to be delivered pursuant to this Section 5.2). Any party from time to time may
change its address, facsimile number or other information for the purpose of
notices to that party by giving notice specifying such change to the other party
hereto.

         6.3      Entire Agreement. This Agreement constitutes the entire
agreement among the parties with respect to the subject matter hereof and
supersedes all prior agreements and understandings, both written and oral, among
the parties with respect to the subject matter hereof.

         6.4      Amendment; Waiver. Additional parties may be added to this
Agreement and any provision of this Agreement may be amended or the observance
thereof may be waived (either generally or in a particular instance and either
retroactively or prospectively), only with the written consent of the Company
and the Holders of a majority of the number of Registrable Securities then
outstanding. Any amendment or waiver effected in accordance with this Section
5.4 shall be binding upon each Investor, Holder of Registrable Securities at the
time outstanding, each future holder of such securities, and the Company.

         6.5      No Assignment; Binding Effect. Neither this Agreement nor any
right, interest or obligation hereunder may be assigned (by operation of law or
otherwise) by any party without the prior written consent of the other party and
any attempt to do so will be void; provided, however, that the rights of a
Holder under this Agreement may be assigned by any Holder in connection with any
transfer or assignment by a Holder of Registrable Securities provided that: (a)
such transfer may otherwise be effected in accordance with applicable securities
laws, (b) such transfer is effected in compliance with the restrictions on
transfer contained in this Agreement and in any other agreement between the
Company and the Holder (including, without limitation, the Equity and Warrant
Agreement and the LLC Agreement), and (c) such other party agrees in writing
with the Company to be bound by all of the provisions of this Agreement. Subject
to the preceding sentence, this Agreement is binding upon, inures to the benefit
of and is enforceable by the parties hereto and their respective successors,
heirs and assigns (including any successor entity of the Company).

         6.6      Heading. The headings and table of contents used in this
Agreement have been inserted for convenience of reference only and do not define
or limit the provisions hereof.

         6.7      Invalid Provisions. If any provision of this Agreement is held
to be illegal, invalid or unenforceable under any present or future law, and if
the rights or obligations of any party hereto under this Agreement will not be
materially and adversely affected thereby, (a) such provision will be fully
severable, (b) this Agreement will be construed and enforced as if such illegal,
invalid or unenforceable provision had never comprised a part hereof, (c) the
remaining provisions of this Agreement will remain in full force and effect and
will not be affected by the illegal, invalid or unenforceable provision or by
its severance herefrom and (d) in lieu of such illegal, invalid or unenforceable
provision, there will be added automatically as a part of this

                                       14
<PAGE>

Agreement a legal, valid and enforceable provision as similar in terms to such
illegal, invalid or unenforceable provision as may be possible.

         6.8      Governing Law. This Agreement shall be governed by and
construed in accordance with the domestic laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or rule (whether
of the State of New York or any other jurisdiction) that would cause the
application of the laws of any jurisdiction other than the State of New York.

         6.9      Jurisdiction; Venue. All actions and proceedings arising out
of or relating to this Agreement shall be heard and determined in any New York
state or federal court sitting in the City of New York, and each party hereby
irrevocably accepts and consents to the exclusive personal jurisdiction of those
courts for such purpose. In addition, each party hereby irrevocably waives, to
the fullest extent permitted by law, any objection which it may now or hereafter
have to the laying of venue of any action or proceeding arising out of or
relating to this Agreement or any judgment entered by any court in respect
thereof brought in any state or federal court sitting in the city of New York
and further irrevocably waives any claim that any action or proceeding brought
in any such court has been brought in an inconvenient forum.

         6.10     Waiver of Trial by Jury. IN ANY ACTION OR PROCEEDING ARISING
HEREFROM, THE PARTIES HERETO CONSENT TO TRIAL WITHOUT A JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM BROUGHT BY ANY PARTY HERETO AGAINST THE OTHER OR
THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH
THIS AGREEMENT, REGARDLESS OF THE FORM OF ACTION OR PROCEEDING.

         6.11     Interpretation. The parties hereto agree that this Agreement
is the product of negotiation between sophisticated parties and individuals, all
of whom were represented by counsel, and each of whom had an opportunity to
participate in and did participate in, the drafting of each provision hereof.
Accordingly, ambiguities in this Agreement, if any, shall not be construed
strictly or in favor of or against any party hereto but rather shall be given a
fair and reasonable construction.

         6.12     Counterparts. This Agreement may be executed in any number of
counterparts, each of which will be deemed an original, but all of which
together will constitute one and the same instrument.

                            [SIGNATURE PAGE FOLLOWS]

                                       15
<PAGE>

         IN WITNESS WHEREOF, the Company and each of the Investors have executed
this Investor Rights Agreement as of the date first written above.

                                       WELLCARE HOLDINGS, LLC

                                       By /s/ Todd Farha
                                         ---------------------------------------
                                         Todd Farha
                                         President and Chief Executive Officer

                                       /s/ Kiran C. Patel
                                       -----------------------------------------
                                       Kiran C. Patel, M.D.

                                       /s/ Pradip C. Patel
                                       -----------------------------------------
                                       Pradip C. Patel

                                       /s/ Rupesh Shah
                                       -----------------------------------------
                                       Rupesh Shah

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}]]